{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:32:31Z","timestamp":1791772351849,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK108327"],"award-info":[{"award-number":["U01DK108327"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["R01CA180057"],"award-info":[{"award-number":["R01CA180057"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["5T32CA090223-13"],"award-info":[{"award-number":["5T32CA090223-13"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Cancer Society Postdoctoral Fellowship","award":["PF-15-156-01-CSM"],"award-info":[{"award-number":["PF-15-156-01-CSM"]}]},{"name":"The Ohio State University Comprehensive Cancer Center (DG)"},{"DOI":"10.13039\/501100007959","name":"ChiRhoClin Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007959","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.pan.2018.11.002","type":"journal-article","created":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T11:56:53Z","timestamp":1541851013000},"page":"80-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6430-1924","authenticated-orcid":false,"given":"Mitchell L.","family":"Ramsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Talbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanios","family":"Bekaii-Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niharika","family":"Badi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Mark","family":"Bloomston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darwin L.","family":"Conwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobeida","family":"Cruz-Monserrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dillhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Farren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Hinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somashekar G.","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory B.","family":"Lesinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Manilchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8083-8492","authenticated-orcid":false,"given":"Anne","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyani V.","family":"Rajasekera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Guttridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil A.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pan.2018.11.002_bib1","first-page":"7","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA A Cancer J Clin"},{"issue":"2","key":"10.1016\/j.pan.2018.11.002_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s13539-010-0015-1","article-title":"Pathophysiology and treatment of inflammatory anorexia in chronic disease","volume":"1","author":"Braun","year":"2010","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.pan.2018.11.002_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clnu.2009.07.001","article-title":"Resting energy expenditure and body composition in patients with newly detected cancer","volume":"29","author":"Cao","year":"2010","journal-title":"Clin Nutr (Edinb)"},{"issue":"9","key":"10.1016\/j.pan.2018.11.002_bib4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.ijo.0801375","article-title":"Validity of self-reported weight and height in the French GAZEL cohort","volume":"24","author":"Niedhammer","year":"2000","journal-title":"Int J Obes Relat Metab Disord : J Int Assoc Study Obesity"},{"issue":"6","key":"10.1016\/j.pan.2018.11.002_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1017\/S1368980011003193","article-title":"Accuracy and reliability of self-reported weight and height in the Sister Study","volume":"15","author":"Lin","year":"2012","journal-title":"Publ Health Nutr"},{"key":"10.1016\/j.pan.2018.11.002_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2458-1-11","article-title":"The validity of self-reported weight in US adults: a population based cross-sectional study","volume":"1","author":"Villanueva","year":"2001","journal-title":"BMC Publ Health"},{"issue":"5","key":"10.1016\/j.pan.2018.11.002_bib7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J\u00a0Clin Invest"},{"issue":"16","key":"10.1016\/j.pan.2018.11.002_bib8","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1158\/1078-0432.CCR-05-0185","article-title":"Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia","volume":"11","author":"Martignoni","year":"2005","journal-title":"Clin Canc Res : Official J Am Assoc Canc Res"},{"issue":"1","key":"10.1016\/j.pan.2018.11.002_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jjco\/28.1.12","article-title":"Elevated serum interleukin-6 levels in patients with pancreatic cancer","volume":"28","author":"Okada","year":"1998","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"10.1016\/j.pan.2018.11.002_bib10","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3892\/ol.2016.5183","article-title":"Growth differentiating factor-15 (GDF-15): a potential biomarker and therapeutic target for cancer-associated weight loss","volume":"12","author":"Lerner","year":"2016","journal-title":"Oncol Lett"},{"issue":"5","key":"10.1016\/j.pan.2018.11.002_bib11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/MPA.0000000000000335","article-title":"Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels","volume":"44","author":"Miura","year":"2015","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.pan.2018.11.002_bib12","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1158\/1078-0432.CCR-15-1732","article-title":"Systemic immune activity predicts overall survival in treatment-naive patients with metastatic pancreatic cancer","volume":"22","author":"Farren","year":"2016","journal-title":"Clin Canc Res : Official J Am Assoc Canc Res"},{"issue":"6","key":"10.1016\/j.pan.2018.11.002_bib13","doi-asserted-by":"crossref","first-page":"e67059","DOI":"10.1371\/journal.pone.0067059","article-title":"Diagnostic and prognostic impact of circulating YKL-40, IL-6, and CA 19.9 in patients with pancreatic cancer","volume":"8","author":"Schultz","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.pan.2018.11.002_bib14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.pan.2017.03.003","article-title":"Inflammatory cytokines and angiogenic factors as potential biomarkers in South African pancreatic ductal adenocarcinoma patients: a preliminary report","volume":"17","author":"Yako","year":"2017","journal-title":"Pancreatology : Official J Int Assoc Pancreatol (IAP)"},{"issue":"3","key":"10.1016\/j.pan.2018.11.002_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10620-008-0390-z","article-title":"Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis","volume":"54","author":"Talar-Wojnarowska","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.pan.2018.11.002_bib16","doi-asserted-by":"crossref","first-page":"e97613","DOI":"10.1371\/journal.pone.0097613","article-title":"Selected cytokines in patients with pancreatic cancer: a preliminary report","volume":"9","author":"Blogowski","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.pan.2018.11.002_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1499-3872(14)60259-9","article-title":"Interleukin-6: a villain in the drama of pancreatic cancer development and progression","volume":"13","author":"Holmer","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int: HBPD INT"},{"key":"10.1016\/j.pan.2018.11.002_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1476-4598-13-114","article-title":"Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease","volume":"13","author":"Shaw","year":"2014","journal-title":"Mol Canc"},{"issue":"2","key":"10.1016\/j.pan.2018.11.002_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/gutjnl-2016-311585","article-title":"IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer","volume":"67","author":"Mace","year":"2018","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.pan.2018.11.002_bib20","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/ijc.29445","article-title":"Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer","volume":"137","author":"Goumas","year":"2015","journal-title":"Int J Canc"},{"issue":"6","key":"10.1016\/j.pan.2018.11.002_bib21","first-page":"1809","article-title":"A\u00a0predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients","volume":"25","author":"Fogelman","year":"2017","journal-title":"Support Care Canc : Official J Multinatl Assoc Support Care Canc"},{"issue":"12","key":"10.1016\/j.pan.2018.11.002_bib22","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/cncr.20672","article-title":"Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis","volume":"101","author":"Ebrahimi","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.pan.2018.11.002_bib23","doi-asserted-by":"crossref","unstructured":"Talbert EE, Lewis HL, Farren MR, Ramsey ML, Rajasekera P, Haverick E, Sarna A, Bloomston M, Pawlik TM, Zimmers TA, et\u00a0al Circulating MCP-1 is associated with cachexia in treatment-naive pancreatic cancer patients [published online ahead of print January 7, 2018]. J Cachexia, Sarcopenia Muscle. doi:10.1002\/jcsm.12251.","DOI":"10.1002\/jcsm.12251"},{"issue":"6","key":"10.1016\/j.pan.2018.11.002_bib24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/mt.2016.66","article-title":"Randomized phase 2 trial of the oncolytic virus pelareorep (Reolysin) in upfront treatment of metastatic pancreatic adenocarcinoma","volume":"24","author":"Noonan","year":"2016","journal-title":"Mol Ther : J Am Soc Gene Therapy"},{"issue":"5","key":"10.1016\/j.pan.2018.11.002_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390318307476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390318307476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:07:33Z","timestamp":1761408453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390318307476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1424390318307476"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2018.11.002","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2018.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 IAP and EPC. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}